FDA chief to detail delays inspecting baby formula plant

Key Facts

• MoneyWatch May 25, 2022 / 11:47 AM / AP Federal plans to inspect a baby formula factory linked to the nationwide shortage were slowed by COVID-19, scheduling conflicts and other logistical problems, according to prepared testimony from the head of the Food and Drug Administration.
• FDA Commissioner Robert Califf is set to answer questions Wednesday from House lawmakers probing the events leading to the formula shortage, which has forced the U.S. to begin airlifting products from Europe while many parents still hunt for scarce supplies in stores.
• The issue is largely tied to problems at Abbott Nutrition's Michigan plant, the largest in the U.S., which the FDA shut down in February due to contamination.
• After detecting positive samples of bacteria in multiple parts of the plant, the FDA closed the facility and Abbott announced a massive recall of its formula on February 17.

Click To Read Full Article